Toggle Nav
Close
  • Menu
  • Setting

Anti-ERBB2/HER2/CD340 Antibody (Disitamab vedotin)

Catalog No.
F1403
Anti-ERBB2/HER2/CD340 Antibody (Disitamab vedotin)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Disitamab vedotin (RC48) is an antibody-active molecule conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated to the cytotoxic agent MMAE via a degradable linker. Disitamab vedotin enhances anti-tumor immunity.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

144.16 kDa

Shipping

Dry ice

Cas No.

2136633-23-1

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

RC48-ADC, RC 48, RC-48

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P04626

Reactivity

Human

Conjugation

MMAE

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

The drug-to-antibody ratio (DAR) of the Anti-ERBB2/HER2/CD340 Antibody (Disitamab vedotin) is 3.8.

Target

ERBB2 / HER2 / CD340

Note

Please avoid freeze-thaw cycles.